Clinicopathological Features of Acute Myeloid Leukemia in a Patient with Phase III Clinical Trial of Tofacitinib (Xeljanz) Therapy for Ulcerative Colitis: A Case Study with Literature Review
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
Ming Xie, Hongwei Ma. "Clinicopathological Features of Acute Myeloid Leukemia in a Patient with Phase III Clinical Trial of Tofacitinib (Xeljanz) Therapy for Ulcerative Colitis: A Case Study with Literature Review." American Journal of Clinical Pathology 146.suppl_1 (2016)